Top Markets
Coin of the day
CytoMed Therapeutics Limited CytoMed Therapeutics Limited

CytoMed Therapeutics Limited

GDTC
Rangering i aksjer #32328
CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical... CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, founded in 2018 and based in Singapore. The firm specializes in creating advanced cellular immunotherapies aimed at combating various human malignancies. Its primary investigational product, CTM-N2D, involves cultivated gamma delta T cells that are engineered with a chimeric antigen receptor (CAR) specifically targeting natural killer group 2D ligands, designed to boost their capacity to destroy cancer cells. Beyond its lead candidate, CytoMed is also advancing iPSC-gdNKT, which utilizes induced pluripotent stem cells (iPSCs) to generate a novel hybrid cell combining properties of both gamma delta T cells and natural killer cells. Additionally, the company is developing CTM-GDT, an immunotherapy consisting of expanded gamma delta T cells that leverages their innate, broad-spectrum recognition system to identify and address diverse cancer types.
Aksjekurs
$0.88
Sist synkronisert: 2026-08-17
Markedsverdi
$10.41M
Endring (1 dag)
-7.26%
Endring (1 år)
-50.56%
Land
SG
Handel CytoMed Therapeutics Limited (GDTC)

Kategori

Historikk for aksjesplitt for CytoMed Therapeutics Limited (GDTC)
Aksjen CytoMed Therapeutics Limited (symbol: GDTC) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 18, 2026.
Én GDTC-aksje kjøpt før Aug 18, 2026 tilsvarer i dag 0 GDTC-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
KR